Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from GP-Act III Acquisition Corporation Class A ( (GPAT) ) is now available.
On March 30, 2026, GP-Act III Acquisition Corp. filed a definitive proxy statement with the U.S. Securities and Exchange Commission to call an extraordinary general meeting, asking shareholders to extend the deadline to complete a business combination and the corresponding trust liquidation date from May 13, 2026 to November 13, 2026. The company and its sponsor plan to enter into non-redemption agreements with third-party shareholders, who would agree not to redeem and to vote for the extensions in exchange for post–business combination share transfers, a move expected to improve the chances of approval and preserve more cash in the trust for the eventual transaction.
The non-redemption agreements will terminate if shareholders do not approve the extension, the parties fulfill their obligations, the company is liquidated or dissolved, the parties mutually agree to end them, or a shareholder redeems or fails to vote for the extension. These arrangements, along with any similar agreements the company may pursue, are designed to stabilize the capital base ahead of the meeting and could materially affect the funds available for the future business combination and the outcome for existing shareholders.
More about GP-Act III Acquisition Corporation Class A
GP-Act III Acquisition Corp. is a Cayman Islands-exempted special purpose acquisition company formed to complete an initial business combination with one or more operating businesses. The company raised capital through an initial public offering of Class A ordinary shares, with proceeds held in a trust account until a suitable merger or similar transaction is consummated.
Average Trading Volume: 147,372
Technical Sentiment Signal: Buy
Current Market Cap: $389.6M
For detailed information about GPAT stock, go to TipRanks’ Stock Analysis page.

